Difference between revisions of "Glypican 3"
Jump to navigation
Jump to search
| Line 10: | Line 10: | ||
===Images=== | ===Images=== | ||
*[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414302/figure/Fig1/ Glypican 3 in UCC (nih.gov)].<ref name=pmid25896897/> | *[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414302/figure/Fig1/ Glypican 3 in UCC (nih.gov)].<ref name=pmid25896897/> | ||
==Positive or negative== | |||
*[[Choriocarcinoma]]. | |||
==See also== | ==See also== | ||
Revision as of 01:02, 30 September 2015
Glypican 3, abbreviated GPC3,[1] is a common immunostain used in gastrointestinal pathology and genitourinary pathology.
Positive
- Hepatocellular carcinoma.[2]
- Malignant melanoma.[2]
- Squamous cell carcinoma of the lung.[2]
- Yolk sac tumour.
- More sensitive than alpha-fetoprotein (AFP).[3]
Images
Positive or negative
See also
References
- ↑ Online 'Mendelian Inheritance in Man' (OMIM) 300037
- ↑ Jump up to: 2.0 2.1 2.2 2.3 Aydin, O.; Yildiz, L.; Baris, S.; Dundar, C.; Karagoz, F. (2015). "Expression of Glypican 3 in low and high grade urothelial carcinomas.". Diagn Pathol 10: 34. doi:10.1186/s13000-015-0266-4. PMID 25896897.
- ↑ Emerson, RE.; Ulbright, TM. (Jun 2010). "Intratubular germ cell neoplasia of the testis and its associated cancers: the use of novel biomarkers.". Pathology 42 (4): 344-55. doi:10.3109/00313021003767355. PMID 20438407.